Published

Strategic Neurodelivery of Psychedelic Compounds: Bridging Molecular Pharmacology with Therapeutic Innovation in CNS Disorders.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: CNS & neurological disorders drug targets
Date: 2026-03-11
Source: PubMed
DOI: 10.2174/0118715273434237251212095005
PubMed: 41833044

Authors

Chauhan SB Akhtar N Jain C Singh I

Watch author

Derived topics and classifications

psilocybin Depression PTSD Addiction Neuroplasticity Pharmacology Mechanism of Action Receptor Pharmacology Safety Toxicity Other

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

Strategic Neurodelivery of Psychedelic Compounds: Bridging Molecular Pharmacology with Therapeutic Innovation in CNS Disorders.2026-03-11

Related papers

Harnessing neuroplasticity with psychoplastogens: the essential role of psychotherapy in psychedelic treatment optimizationFrontiers in Psychiatry · 2025-04-08 Editorial: Psychedelic-assisted psychotherapies: from clinical trials to credibility.Frontiers in neuroscience · 2026-01-01 Psilocybin-assisted neurofeedback for the improvement of executive functions: a randomized semi-naturalistic-lab feasibility study.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2024-12-02 A Double-Blind Trial of Psilocybin-Assisted Treatment of Alcohol DependenceClinicalTrials.gov · 2022-11-08 Occurrence of psilocybin in the sporophores of Psilocybe semilanceataTransactions of the British Mycological Society · 1969-10-01 Pilot Study: Effects of Psilocybin on Behavior, Psychology and Brain Function in Long-term MeditatorsClinicalTrials.gov · 2014-05-20 Crystal structures of the Teonanácatl hallucinogens. Part I. Psilocybin C12 H17 N2 O4 PJournal of the Chemical Society Perkin Transactions 2 · 1974-01-01 Crystal structures of the Teonanácatl hallucinogens. Part II. Psilocin, C12 H15 N2 OJ. Chem. Soc., Perkin Trans. 2 · 1974-01-01